The FDA has approved upadacitinib, a Janus kinase inhibitor, for the treatment of giant cell arteritis in adults-marking the ...

AbbVie’s Rinvoq (upadacitinib) has been approved by the US Food and Drug Administration (FDA) to treat adults with giant cell ...

AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib), 15 mg, once daily, ...

The FDA has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).

AbbVie announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA). This comes after the ...

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 ...

The good news? With proper treatment—whether it’s medication, lifestyle changes or both—many can find lasting relief. And for those with tougher cases new research is expanding treatment ...

However, a new study has comprehensively evaluated current drug and non-drug therapies to provide up-to-date guidelines to inform treatment options for those with the condition. It’s estimated ...

Early recognition of this pattern can lead to more effective treatment before the condition becomes debilitating. 4. Temporal arteritis: When blood vessels inflame Temporal arteritis, also known ...

Dr. Kyle Benda is a director of medical operations at Whitman-Walker Health, a nonprofit in Washington, D.C., that offers primary care and specializes in HIV treatment. He credits PrEP with ...

The type of treatment you get depends on whether it’s acute or chronic and what’s causing it. Generally, acute hyperkalemia needs emergency treatment, whereas chronic hyperkalemia can be ...

Between 2021 and 2023, use of GLP-1RA-based medications surged, especially tirzepatide, highlighting evolving prescribing patterns and the growing focus on obesity treatment. When it comes to managing ...